No Data
Japan Stocks Rally on US Fed Rate Cut Hopes
Afternoon session [Active stocks and traded stocks]
*Cell Source <4880> 1052 +30 Cooperation with Docomo, reached agreement for cooperation consideration with Japan Post. *Dejiha HD <3676> 830 +3623 Sales revenue Financial Estimates for the fiscal year ending March 2025 have been downwardly revised, but net profit Financial Estimates have been upwardly revised. *Pivan <3559> 382 +17 Announced that the previously undecided Dividends for the fiscal year ending March 2025 are expected to be 10 yen, an increase of 2 yen compared to the previous period. *Silver Life <9262> 724 -45 First quarter operating profit decreased by 29.4%. *Perseus <4882> 663 -
Digital Hearts to Book Extraordinary Income of 400 Million Yen; Boosts Fiscal 2025 Forecast
12/12 [Today's Investment Strategy]
[FISCO Specially Selected Brand] [Material Brand] Pharma Foods ＜2929＞ 958 yen (12/11) Mainly sells supplements and cosmetics. They also work on functional materials. First quarter financial results have been announced. Operating profit was 0.882 billion yen (up 46.7% from the same period last year). The cumulative number of shipments of “Pneumo Hair Growth Agent” has exceeded 29 million units as of November 19. Other product groups emphasized profitability indicators, and advertising costs were suppressed. Operating profit for the fiscal year ending 25/7 is expected to be 2 billion yen (down 60.9% from the previous fiscal year)
Focus on Pharma F and Cell Source, while Kura Sushi and Synchro Food are sluggish.
In the US stock market on the 11th, the Dow Jones Industrial Average fell by $99.27 to 44,148.56, the Nasdaq Composite Index increased by 347.65 points to 20,034.90, and the Chicago Nikkei 225 Futures rose by 655 yen compared to the Osaka daytime to 40,065 yen. The exchange rate is 1 dollar = 152.40-50 yen. In today's Tokyo market, Tosa Industries <6309> announced an operating profit forecast of a 16.2% increase from the previous period and a 5.5% increase for the current period, while Pharma F <2929> reported a 46.7% increase in operating profit for the first quarter, and in November, the entire company...
Kurazushi, for the fiscal year ending October 2024, operating profit increased by 132.0% to 5.699 billion yen, while the financial estimates for the year ending October 2025 project a decrease of 12.3% to 5 billion yen.
Kurazushi (2695) announced that its performance for the fiscal year ending October 2024 saw revenue increase by 11.1% year-on-year to 234.9 billion 50 million yen, and operating profit increased by 132% to 5.6 billion 99 million yen. For the fiscal year ending October 2025, revenue is projected to increase by 3.4% year-on-year to 243 billion yen, while operating profit is planned to decrease by 12.3% to 5 billion yen. From the perspective of fair profit return to shareholders, including dividends, the shareholder benefit program will be abolished. A commemorative dividend of 20 yen per share will be implemented, in addition to a dividend of 40 yen per share.
No Data